BioSpace News Archive

Today, one thing is crystal clear: change is the new normal in the life sciences industry. Organizations are looking for leaders who are future-focused and able to handle whatever comes their way. Maintaining the status quo is no longer good enough.

Sanofi, Lead Pharma’s collaborative partner in the development of SAR441169, successfully initiated first human dosing with this novel RORγt Inverse Agonist candidate treatment

Researchers from Xi’an Jiaotong-Liverpool University have completed a high-resolution prediction of the whole-transcriptome m6A RNA modification, successfully creating the world’s most accurate map of the m6A epitranscriptome.

Three-year follow-up data show comparable overall survival between biosimilar ONTRUZANT® (trastuzumab) and reference medicine HERCEPTIN®i (trastuzumab)ii in early and locally advanced HER2-positive breast cancer

Computed tomography is used excessively for scanning dental infections even though history and physical examinations can help correctly diagnose higher-risk infections before having patients undergo the scanning, which is associated with high costs and long-term potential for cancer, according to a study published in the March issue of the Journal of Oral and Maxillofacial Surgery.

Novocure (NASDAQ: NVCR) today announced the retirement of Dr. Eilon Kirson, Novocure’s Chief Science Officer and Head of Research and Development, effective May 1, 2019.

Aerie Pharmaceuticals, Inc. announced the commencement of patient dosing in its Phase 2 clinical trial designed in accordance with the requirements of Japan’s PMDA to support potential regulatory submission of netarsudil ophthalmic solution in Japan.

PKU GOLIKE®, the brand new generation of Phenylalanine-free medical food for Phenylketonuria dietary management, is now available in Germany and Austria, promoted and distributed directly by APR Applied Pharma Research s.a. through its local subsidiary, APR Deutschland.

Non-profit convenes board of directors, launches executive director search, begins work of establishing strategic priorities

Multiple studies and new data clarifying the Addyi and alcohol interaction for both the medical community and patients were formally submitted to the FDA as well as presented to The International Society for the Study of Women’s Sexual Health (ISSWSH), International Society for Sexual Medicine (ISSM) and Sexual Medicine Society of North America (SMSNA).